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ABSTRACT
In Drosophila, SU(VAR)3-7 is an essential hetero-
chromatin component. It is required for proper
chromatin condensation, and changing its dose
modifies position-effect variegation. Sumoylation is
a post-translational modification shown to play a
role in diverse biological processes. Here, we dem-
onstrate that sumoylation is essential for proper
heterochromatin function in Drosophila through
modification of SU(VAR)3-7. Indeed, SU(VAR)3-7 is
sumoylated at lysine K839; this modification is
required for localization of SU(VAR)3-7 at pericentric
heterochromatin, chromosome 4, and telomeres.
In addition, sumoylation of SU(VAR)3-7 is a pre-
requisite for its ability to enhance position-effect
variegation. Thus, these results show that the het-
erochromatic function of SU(VAR)3-7 depends on its
own sumoylation, and unveil a role for sumoylation
in Drosophila heterochromatin.
INTRODUCTION
Heterochromatin represents the condensed part of
chromosomes, characterized by a high content of repeti-
tive elements and low gene density. In Drosophila, it is
found mainly in pericentric regions, at telomeres and
chromosome 4 (1). SU(VAR)3-7 is a key component of
Drosophila heterochromatin essential for chromosome
structure and heterochromatin formation (2–4). The
Su(var)3-7 gene was historically identiﬁed in genetic
screens, together with Su(var)3-9 and Su(var)2-5
[encoding respectively SU(VAR)3-9 and heterochromatin
protein 1 (HP1)], as haplo-suppressors and triplo-
enhancers of position-eﬀect variegation (PEV) [(5) and
references in (6)]. PEV reﬂects the mosaic and stochastic
heterochromatin-induced silencing of genes located in
the vicinity of heterochromatin. Loss of one dose of
Su(var)3-7, Su(var)3-9, or Su(var)2-5, suppresses the
genomic silencing of variegating genes, while a triple
dose enhances it. Su(var)3-7, Su(var)3-9 and
Su(var)2-5 were thereafter shown to encode key structural
and enzymatic components of heterochromatin (6,7).
The product of the Su(var)3-7 gene, SU(VAR)3-7, is
composed of seven N-terminal zinc ﬁnger domains with
high aﬃnity for DNA, and of the C-terminal Bess- and
BoxA-motifs involved in self-interaction and in speciﬁc
heterochromatin association (5,8,9). SU(VAR)3-7 local-
izes mainly at pericentric heterochromatin, together with
SU(VAR)3-9 and HP1 (1,10). SU(VAR)3-9 is the hetero-
chromatic histone H3 lysine 9 (H3K9) methyltransferase
(KMTase) (also referred to KMT1), that dimethylates and
trimethylates H3K9 at pericentric heterochromatin and at
the core of the chromocenter, respectively (11–13). In this
way, it forms a docking site for the recruitment of HP1
through its chromodomain (14–16). SU(VAR)3-7 inter-
acts genetically and physically with SU(VAR)3-9 and
HP1 (2,10,13,17), and its presence at heterochromatin is
HP1-dependent (4). Moreover, SU(VAR)3-7 and HP1 as-
sociate with telomeres, chromosome 4, and with a few
euchromatic sites among which the well characterized
region 31 of chromosome 2 (10,17–20). At these positions,
H3K9 methylation is present, but deposited by other
H3K9 KMTases, DmSETDB1 at chromosome 4 (21),
and possibly G9a at euchromatic regions (22).
Consistent with its role in heterochromatin formation,
overexpression of SU(VAR)3-7 leads to further condensa-
tion, and absence of it to decondensation of chromatin,
most strikingly at the chromocenter and the male X
chromosome (2,4), the eﬀect on the male X chromosome
being due to an interaction between heterochromatin and
dosage compensation (23).
Sumoylation is an essential post-translational modiﬁ-
cation, featuring a SUMO (small ubiquitin-related
modiﬁer) molecule (Smt3 in Drosophila) that is covalently
conjugated to a protein substrate (for reviews on
sumoylation, see for example (24,25). A growing number
of proteins were shown to be dependent on sumoylation
for proper regulation, and sumoylation plays a role in
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several biological processes, such as for instance cell
survival and proliferation, transcriptional regulation,
intracellular traﬃcking, and maintenance of telomeric
and nuclear organization (25–27). The sumoylation
reaction cascade is similar to ubiquitination, involving
the E1-activating enzyme (Aos1/Uba2 heterodimer in
Drosophila), the E2-conjugating enzyme (Ubc9, encoded
by lwr in Drosophila), and several E3-ligases mediating
substrate speciﬁcity. The SUMO molecule is attached to
the "-NH2 group of lysine (K) residues usually located
within the KxE (where  is a large hydrophobic
amino acid) consensus target site (28). This modiﬁcation
is dynamic and reversible, since SUMO molecule can be
cleaved by speciﬁc proteases (29). Sumoylation can have
several functional outcomes; it can alter the activity of a
protein, change its sub-cellular localization, or create a
new platform for interaction with another protein
(25,26). Indeed, the SUMO moiety is recognized by
partners bearing a SUMO-interacting motif (SIM) (30).
Cross-talk with other post-translational modiﬁcations,
such as phosphorylation (31), adds an additional level of
regulation to these modiﬁcations. In Drosophila,
sumoylation has been involved in embryogenesis, wing
morphogenesis, central nervous system development,
immune system (32), Ras signaling, cell cycle control,
and embryonic patterning (33). Several lines of evidence
also implicate sumoylation in certain aspects of chromo-
some regulation, namely lwr (encoding the E2-conjugating
Ubc9 enzyme) in the dissociation of heterochromatic
regions of homologs at the end of the meiotic prophase
(34), SUMO in the negative regulation of the activity of
the gypsy chromatin insulator (35), and the SU(VAR)2-10
E3-ligase in the establishment and maintenance of
chromosome organization in interphase (36). Given this
diverse array of functions, it appears reasonable to
assume that sumoylation could also be involved in add-
itional, yet undiscovered biological processes in
Drosophila.
Here, we show that sumoylation is required for hetero-
chromatin function in Drosophila, through the modiﬁca-
tion of SU(VAR)3-7. We demonstrate that SU(VAR)3-7
is sumoylated, and identify the target lysine. We also show
that sumoylation is necessary for proper heterochromatic
localization of SU(VAR)3-7, and for its ability to enhance
PEV. Thus, these results reveal a role for sumoylation in
Drosophila heterochromatin, mediated by SU(VAR)3-7
modiﬁcation.
MATERIALS AND METHODS
Drosophila lines and generation of transgenic lines
The Su(var)3-7R2a8 allele was described in ref. (4). The
lwr4-3 and lwr5 alleles were described in (34) and were a
gift from Soichi Tanda. In(1)wm4h and Heidi were
described in (37) and (38). daGal4.w- (Bloomington
stock #8641) was a gift from J.M. Dura. For the gener-
ation of the transgenic lines, 3HA-Su(var)3-7(WT) and
(K839R) variant coding sequences were cloned in the
C4yellowUAST vector. Constructs were injected into yw
embryos with the pUChspdelta2-3 plasmid at a 3:1 ratio.
Transgenic ﬂies were selected with the yellow marker.
Expression was induced by the daGal4 or daGal4.w-
driver.
DNA constructs
For Su(var)3-7, the cDNA encoding amino acids 82–1250
was cloned downstream of EGFP, and the cDNA
encoding amino acids 1–1250 was cloned downstream of
the 3HA tag. Point mutations were generated by PCR.
SUMO and ubiquitin cDNAs were cloned downstream
of the 3HA. For expression in S2 cells, constructs were
cloned in the pMT vector. pMT was generated from pMT/
V5-HisB (Invitrogen), where the V5-His6 tag was removed
by BstBI-PmeI double digestion, blunting and self-
ligation. All constructs were veriﬁed by sequencing.
Cloning details are available upon request.
Cell culture and transfection
S2 cells were cultivated in Schneider’s Drosophila
medium (Invitrogen) supplemented with 1 Penicillin–
Streptomycin–Glutamin and 10% heat inactivated fetal
calf serum (Invitrogen). For each transfection, 950 ng of
linearized expression construct(s) (in the pMT vector)
were cotransfected with 50 ng of linearized pCoblast
(Invitrogen) using the FuGene6 reagent (Roche). Twenty
four hours after transfection, integrative transfectants
were selected with 25 mg/ml blasticidin for at least
5 days. After selection, expression of the cDNA constructs
was induced for 3 days with 50 mM CuSO4.
Immunoprecipitation
Proteins were extracted from fresh S2 cell pellets or from
frozen canton S embryos with 150mM NaCl, 50mM
Tris pH 7.4, 1mM EDTA, 1% NP40, 0.25% sodium
deoxycholate, 1mM PMSF, 1mM NEM, and anti prote-
ases (complete, Roche). Rabbit antibodies directed against
SU(VAR)3-7 [20ml Ab212 (10) or 20 ml Ab1399] were
preincubated with 25 ml protein G agarose (Roche) in
150mM NaCl, 50mM Tris pH 7.4, 1mM EDTA, 0.1%
NP40, 1mM PMSF, 1mM NEM, anti proteases
(complete, Roche). An amount of 500 mg extract were
incubated with the beads-antibody complex in 1ml ﬁnal
150mM NaCl, 50mM Tris pH 7.4, 1mM EDTA, 0.1%
NP40, 1mM PMSF, 1mM NEM, anti proteases
(complete, Roche) for 2 h at 4C on a wheel. Beads were
washed three times with the same buﬀer, and the one-tenth
of the immunoprecipitated material was analyzed by
western blot.
Western blot analysis
Proteins from cultured cells were extracted from frozen
pellets with 150mM NaCl, 50mM Tris pH 7.4, 1mM
EDTA, 1% NP40, 0.25% sodium deoxycholate, 1mM
PMSF, and anti proteases (complete, Roche). Protein
extracts from brain, salivary glands and imaginal discs
of third instar larvae were prepared as described (21).
Western blot analyses were performed as described (21),
with the following primary antibodies: a-HA
(MMS-101R, Covance, 1/2000), a-GFP (11814460001,
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Roche, 1/1000), a-alpha-Tubulin (T9026, Sigma, 1/5000),
a-SU(VAR)3-7 Ab212 (10) (1/750) or Ab1399 (1/750),
a-SUMO (1/2000) (a gift from A.J. Courey).
Eye pigment measurement
Each measure was done as a triplicate. Three days old
adults were frozen. Ten heads were collected, resuspended
in 50 ml 30% ethanol pH 1.5, and squashed. An amount of
950 ml 30% ethanol pH 1.5 were added and samples were
incubated in 24-wells plates O/N at 37C to extract
pigments. Samples were centrifuged, the supernatants
were collected, and the pigments values were measured
with a spectrophotometer at OD 480 nm.
Immunostaining of polytene chromosomes and whole
mount salivary glands
Polytene chromosomes immunostainings were performed
as described in (21). Slides were hybridized with a-HA
(MMS-101R, Covance, 1/200) and a-HP1 (a gift from L.
Wallrath, 1/100) as primary antibodies. For
immunostaining of whole mounts, salivary glands were
dissected in PBS, ﬁxed for 20min in PBS 4% formalde-
hyde, washed two times with PBT (PBS, 0.5% Tween-20),
washed six times with BBT (PBS, 0.5% TritonX-100, 1%
BSA), incubated overnight at 4C in BBT with the a-HA
(MMS-101R, Covance), washed six times with BBT,
incubated 2 h at RT with the secondary antibody (Alexa
Fluor 555 goat anti-mouse IgG No A21422, Invitrogen),
washed two times with BBT, three times with PBT,
incubated 50 with DAPI in PBT, washed once with PBT,
and mounted in Vectashield (Vector Laboratories).
Confocal images of whole mount salivary glands were
taken with a Leica TCS SP2 AOBS microscope.
RESULTS
SU(VAR)3-7 is modiﬁed by SUMO at lysine K839
The ﬁrst indication that SU(VAR)3-7 is post-
translationally modiﬁed comes from western blot
analysis. Indeed, tagged versions of SU(VAR)3-7 ex-
pressed from a cDNA transfected in S2 cells or from a
cDNA transgene appear as a major band at approximate-
ly 200 kDa, with an additional band of signiﬁcant higher
molecular weight (see e.g. Figures 1A and G). The upper
band is not due to phosphorylation of SU(VAR)3-7, as it
is resistant to phosphatase treatment (data not shown).
Two other post-translational modiﬁcations were then
considered, namely sumoylation and ubiquitination.
To address this issue, a GFP-tagged version of amino
acids 82–1250 of SU(VAR)3-7 (GFP-Su(var)3-7) was
co-expressed in S2 cells with 3HA-tagged SUMO
(3HA-SUMO) or with 3HA-tagged ubiquitin (3HA-ubi).
These exploratory experiments were performed with a
truncated yet functional protein (39). Indeed, when this
work was initiated, the 81 amino acid N-terminal exten-
sion of SU(VAR)3-7 was not yet known. For this reason,
the results were subsequently conﬁrmed with the
full-length protein (Figure 1F). If SU(VAR)3-7 were to
be SUMO or ubiquitin modiﬁed, part of the upper band
should increase in size due to the 3HA-tag carried by the
co-transfected 3HA-SUMO or 3HA-ubi. Figure 1A eﬀect-
ively shows that GFP-SU(VAR)3-7 displays an additional
third band above the doublet when co-expressed with
3HA-SUMO, but not with 3HA-ubi, suggesting that
SU(VAR)3-7 is subjected to sumoylation. To strengthen
this further, the experiment was repeated in the presence
of the SUMO isopeptidase Ulp1 (40). Upon co-expression
of Ulp1, the SUMO and 3HA-SUMO modiﬁed
forms of SU(VAR)3-7 disappear, further conﬁrming
that SU(VAR)3-7 is sumoylated (Figure 1B). We next ad-
dressed whether the endogenously expressed SU(VAR)3-7
was also sumoylated. Therefore, endogenous
SU(VAR)3-7 protein was immunoprecipitated from S2
cells, and analyzed by western blot with antibodies
speciﬁc for SU(VAR)3-7 or SUMO. Figure 1C shows
that SU(VAR)3-7 displays one band corresponding to
the non-modiﬁed form (square), and one band of higher
molecular weight corresponding to the sumoylated
SU(VAR)3-7 (circle). The identity of these two bands
was conﬁrmed by parallel analysis of an extract from
cells overexpressing SU(VAR)3-7 (data not shown). In
addition, two bands of even higher molecular weight are
present (stars). The three upper bands, but not the one
corresponding to the non-sumoylated SU(VAR)3-7, are
recognized by the a-SUMO (Figure 1C). Similar results
were obtained with another SU(VAR)3-7 antibody or
with proteins extracted from embryos (Supplementary
Figure S1). Thus, SU(VAR)3-7 can accommodate
several SUMO molecules, probably when expressed at
low level (see ‘Discussion’ section). In summary, three
lines of evidence show that SU(VAR)3-7 is sumoylated:
(i) the band corresponding to sumoylated SU(VAR)3-7 is
shifted upon co-expression of 3HA-SUMO, (ii) the
modiﬁed forms disappear in presence of the SUMO
isopeptidase Ulp1, and (iii) the modiﬁed forms of
SU(VAR)3-7 are recognized by an a-SUMO.
SUMO molecules are covalently attached to lysines,
according to the KxE/D consensus (28). The
SUMOplotTM Analysis Program (http://www.abgent
.com/tool/sumoplot) predicts and scores sumoylation
sites in any protein based on the presence of the SUMO
consensus sequence. When the full-length SU(VAR)3-7
protein sequence (amino acids 1–1250) was analyzed
with this program, the lysine 269 (K269) displayed the
highest score. K269 was mutated into an arginine
in GFP-Su(var)3-7 (GFP-Su(var)3-7(K269R)) and this
construct was transfected into S2 cells, with or without
the 3HA-SUMO. Western blot analysis shows that the
SUMO-modiﬁcation is still present on GFP-SU
(VAR)3-7(K269R) (Figure 1D). We then mutated the
three next lysines displaying the highest scores in the
SUMOplotTM analysis into arginines, namely K813,
K1056 and K982. Mutations were done in a cumulative
manner, because loss of a major sumoylation site could
lead to sumoylation at secondary minor sites.
Sumoylation still occurs on the protein carrying all four
substitutions (data not shown). Four additional lysines
were then cumulatively mutated (K134, K254, K508,
K727), resulting into a molecule with eight lysines
replaced by arginines (named 8KR), and again
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Figure 1. SU(VAR)3-7 is sumoylated at lysine K839. (A) Sumoylation of SU(VAR)3-7. A GFP-Su(var)3-7 construct (amino acids 82–1250) or the
empty vector (vect) were transfected in S2 cells together with the empty vector, 3HA-SUMO, or 3HA-ubi. Western blot analysis with an a-GFP
shows the diﬀerent forms of GFP-SU(VAR)3-7, namely a doublet when expressed alone, and an additional band when co-expressed with
3HA-SUMO. 3HA-SUMO and 3HA-ubi are both expressed (data not shown). (B) Proﬁle of SU(VAR)3-7 upon co-expression of Ulp1.
GFP-SU(VAR)3-7 was expressed with 3HA-SUMO or the empty vector, and with or without Ulp1. DNA amount was kept constant in transfections
with empty vector. Proteins were analyzed as in A. (C) Sumoylation of the endogenous SU(VAR)3-7 protein. Total proteins were extracted from S2
cells and endogenous SU(VAR)3-7 was immunoprecipitated from 500mg total extract with a-SU(VAR)3-7 Ab1399. One-ﬁftieth of the total extract
(input), one-tenth of the negative control IP without antibody (neg) and one-tenth of the IP (IP) were loaded twice and analyzed by western blot with
a-SU(VAR)3-7 Ab1399 or a-SUMO. The identity of the bands was veriﬁed by running in parallel extract from cells overexpressing SU(VAR)3-7
(data not shown). Square: non-modiﬁed SU(VAR)3-7. Circle: sumoylated SU(VAR)3-7. Stars: SU(VAR)3-7 with possibly several molecules
of SUMO or other additional post-translational modiﬁcations (see discussion). (D) Sumoylation of the K269R mutated form.
GFP-SU(VAR)3-7(WT) or (K269R) expressed with the empty vector or 3HA-SUMO were analyzed as in A. (E) Lack of sumoylation in the
SU(VAR)3-7(K839R) mutant. GFP-SU(VAR)3-7(WT), with eight or nine K to R substitutions (8KR or 9KR), or with the K839R substitution,
were expressed with 3HA-SUMO or the empty vector. Proteins were analyzed as in A. (F) Absence of sumoylation in the 3HA-tagged full-length
SU(VAR)3-7 bearing the K839R substitution. 3HA-Su(var)3-7 full-length (amino acids 1–1250) constructs, namely WT, 9KR and K839R mutant
forms, or the empty vector, were expressed in S2 cells together with the empty vector or 3HA-SUMO. Proteins were analyzed as in A., but with
a-HA. (G) Expression of 3HA-SU(VAR)3-7(WT) and (K839R) in transgenic lines. Western blot analysis on brain, salivary glands, and imaginal discs
(dissected together) protein extracts of control, 3HA-SU(VAR)3-7(WT) or (K839R) expressing third instar larvae. Membranes were cut and probed
with a-HA and a-tubulin. Genotypes are the following: lane 1: yw; P{daGal4. w}/+. Lane 2: yw;P{UAST-3HA-Su(var)3-7(WT); y+}/+;
P{daGal4.w}/+. Lane 3: yw; P{UAST-3HA-Su(var)3-7(K839R); y+}/+; P{daGal4.w}/+.
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SU(VAR)3-7 retained sumoylation (Figure 1E). Mutation
of a ninth lysine, K839, resulted into a molecule (9KR)
that could not be sumoylated anymore (Figure 1E). The
K839R substitution, when present in an otherwise
wild-type background, recapitulates the same ﬁnding,
since the resulting protein is not sumoylated (Figure 1E).
Given that the single K839R change abolishes
sumoylation, we conclude that K839 is the main lysine
modiﬁed by SUMO in SU(VAR)3-7. As mentioned, the
full-length protein is 1250 amino acids long [sequence can
be found in GenBank (AAF54918) or (09)]. An initially
non characterized in frame ATG is located 243-bp
upstream of the second ATG (in the same exon), resulting
into a protein with an 81 amino acid N-terminal extension.
Thus, the results were conﬁrmed with full-length
3HA-tagged SU(VAR)3-7 constructs. Similarly as the
truncated form, full-length SU(VAR)3-7 is sumoylated
at position K839 (Figure 1F). Full-length
3HA-Su(var)3-7 constructs were used henceforth for
functional in vivo studies.
Sumoylation of SU(VAR)3-7 is required for
localization at heterochromatin
SU(VAR)3-7 is a heterochromatic protein associated with
pericentric heterochromatin, chromosome 4, region 31
and telomeres (4,10,17). We therefore asked whether
sumoylation is required for its proper localization. To
this end, we generated transgenic lines with full length
3HA-Su(var)3-7(WT) or (K839R) placed downstream
of the UAS element. The transgenes were expressed with
the daGal4 or the daGal4.w driver. In vivo, the non
modiﬁed 3HA-SU(VAR)3-7 wild-type and mutant
proteins are expressed at similar levels (Figure 1G). The
wild-type form displays a SUMO-modiﬁed upper band
that is almost as intense as the non-modiﬁed form, as
well as a faint band of higher molecular weight possibly
corresponding to a protein carrying two SUMO molecules
(Figure 1G). In a parallel experiment, the SU(VAR)3-7
protein expressed from the previously published HA:FL
transgenic line (39) was reanalyzed; this construct also
produces SU(VAR)3-7 modiﬁed forms (Supplementary
Figure S2). The 3HA-SU(VAR)3-7(K839R) generates
two upper bands, both of them much weaker than
the wild-type. Thus, sumoylation of the 3HA-SU
(VAR)3-7(K839R) is strongly reduced (Figure 1G); the
residual signal could represent sumoylation at alternative
sites in absence of the major site, or could reﬂect other
post-translational modiﬁcations.
The transgenic lines were further used to localize
3HA-SU(VAR)3-7(WT) and (K839R) in whole mount
salivary glands and on chromatin. These experiments
were performed in the Su(var)3-7R2a8 deletion null
mutant background to avoid potential homo-dimerization
with the endogenous wild-type protein. Whole mount
salivary glands of third instar larvae stained with an HA
antibody show that both wild-type and mutant proteins
are expressed and present in the nucleus (Figure 2A, ﬁrst
lane). The pictures were then taken at higher magniﬁca-
tion with a confocal microscope. The
3HA-SU(VAR)3-7(WT) protein preferentially localizes
at chromatin dense regions and at some distinct bands, a
pattern reminiscent of polytene chromosomes (see below).
In contrast, 3HA-SU(VAR)3-7(K839R) shows no prefer-
ential chromatin association (Figure 2A, second lane).
In conclusion, analysis of whole mount salivary glands
shows that the non-sumoylable SU(VAR)3-7 variant,
despite its nuclear localization, does not bind to chromatin
dense regions similarly as the wild-type form.
On polytene chromosomes, 3HA-SU(VAR)3-7(WT)
localizes at the chromocenter, telomeres, chromosome 4
(Figure 2B) and region 31 (data not shown), as described
for the endogenous protein. Similarly, HP1 also localizes
properly, namely at the chromocenter, telomeres, chromo-
some 4 and region 31 (Figure 2B). However, staining of
polytene chromosome of larvae expressing 3HA-SU
(VAR)3-7(K839R) revealed that the non-sumoylable
protein does not co-localize with chromatin dense
regions (Figure 2C). Co-staining of these polytene
chromosomes with an HP1 antibody demonstrated a
similar localization as in the wild-type (Figure 2C). The
observed pattern for 3HA-SU(VAR)3-7(K839R) is identi-
cal in male and female larvae (Supplementary Figure S2).
Taken together, these data show that SU(VAR)3-7
localization at pericentric heterochromatin, telomeres,
chromosome 4 and region 31 requires post-translational
modiﬁcation by SUMO at lysine K839. On the other
hand, sumoylation of SU(VAR)3-7 is not required for
proper localization of HP1.
Sumoylation of SU(VAR)3-7 is required for
enhancement of PEV
One of the main features of Su(var)3-7 is its ability to
inﬂuence PEV (6). We therefore asked next whether this
property was dependent on its sumoylation. Two PEV
reporter lines were used, the In(1)wm4h line, where an in-
version relocates the endogenous white gene next to
centromeric heterochromatin, and the Heidi line (38),
which has a P element containing the white gene relocated
near centromeric heterochromatin of chromosome 2.
Before testing the role of sumoylation of SU(VAR)3-7 in
PEV, we ﬁrst analyzed whether sumoylation per se was
involved in this phenomenon. In other words, we tested
whether loss of one dose of the ubiquitin-E2 ligase
encoded in Drosophila by the lesswright (lwr) gene inﬂu-
ences PEV. Two alleles of the lwr gene were used, lwr4-3
and lwr5; both are recessive lethal and UAS-lwr transgene
can rescue the lethality (34). In In(1)wm4h and Heidi lines,
the variegating white gene is more expressed in the lwr
heterozygous mutant than in lwr+ homozygous
wild-type background (Figure 3A, left part and data not
shown). This argues in favor of a role for sumoylation
in the repression of these variegating genes. The same
experiment was performed with the In(1)wm4h line, in
the presence of an additional copy of Su(var)3-7 [with
the T21A line (5)]. Due to this additional dose of
Su(var)3-7, PEV is enhanced in the lwr+wild-type back-
ground. This is not the case in the lwr heterozygous
mutant backgrounds (Figure 3A, right part), again
underscoring that sumoylation plays a role in PEV.
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We next undertook to look speciﬁcally at the role
of sumoylation of SU(VAR)3-7 itself in PEV. We
compared the variegated phenotype of the Heidi line, in
the presence of an excess of 3HA-SU(VAR)3-7(WT) or
(K839R). Overexpression of the wild-type protein, but
not of the K839R non-sumoylable variant, enhances
variegation in males and females (Figure 3B),
demonstrating that the property of SU(VAR)3-7 to
enhance variegation requires its own sumoylation. Taken
together, these results show that the previously described
3HA-SU(VAR)3-7 WT
3HA-SU(VAR)3-7 (K839R)
3HA-SU(VAR)3-7 WTA
B
C
3HA-SU(VAR)3-7 (K839R)
DAPI a-HADAPI
chr4chr4
C
r31 teltel
C
r31 tel
tel
a-HP1
a-HP1
a-HP1DAPI DAPI
chr4chr4
C
tel
tel
tel
C
tel tel
tel
IPADIPAD
C
r31
tel
tel
C
r31
tel
tel
C
r31
tel
telDAPI
chr4chr4 chr4
DAPI
DAPI a-HA
a-HAa-HA
a-HA
a-HA
a-HA
a-HA DAPI
a-HP1
Figure 2. Sumoylation of SU(VAR)3-7 is required for localization at heterochromatin. (A) Expression and cellular localization of
3HA-SU(VAR)3-7(WT) and (K839R) proteins. Whole mount salivary glands of yw; P{UAST-3HA-Su(var)3-7(WT)or(K839R); y+}/
P{UAST-3HA-Su(var)3-7(WT)or(K839R); y+}; Su(var)3-7R2a8/ P{daGal4; w+} Su(var)3-7R2a8 third instar larvae were stained with a-HA. First
lane shows whole salivary glands, second lane enlargements of the nuclei (pictures taken on a confocal microscope). (B) Localization of
3HA-SU(VAR)3-7(WT) and HP1 on chromatin. Polytene chromosomes of larvae expressing 3HA-SU(VAR)3-7(WT) were stained with a-HA or
a-HP1. DNA was stained with DAPI. Genotypes are the same as in Figure 2A. ‘C’ stands for chromocenter, ‘tel’ for telomere, ‘r31’ for region 31,
and ‘chr4’ for Chromosome 4. (C) Localization of 3HA-SU(VAR)3-7(K839R) and HP1 on chromatin. Polytene chromosomes of larvae expressing
3HA-SU(VAR)3-7(K839R) were stained with a-HA and a-HP1 together. Genotypes and arrows codes are the same as in Figure 2A and B.
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functions and characteristics of SU(VAR)3-7, namely het-
erochromatic localization and ability to enhance PEV, rely
on the post-translational modiﬁcation of SUMO on lysine
at position K839.
DISCUSSION
Our data show that sumoylation of SU(VAR)3-7 is
required for its proper heterochromatic function in
Drosophila. Indeed, sumoylation of SU(VAR)3-7 at
lysine K839 is a prerequisite for heterochromatin localiza-
tion, and for the ability of SU(VAR)3-7 to enhance PEV.
To our knowledge, the speciﬁc requirement of
sumoylation for the function of a heterochromatic
protein in Drosophila had not been demonstrated before.
Thus, in addition to its role in regulating multiple bio-
logical processes, sumoylation also plays a role in
Drosophila heterochromatin.
SUMO modiﬁcation of SU(VAR)3-7 was demonstrated
by four approaches: (i) the shift of the modiﬁed form upon
co-expression of 3HA-SUMO (Figure 1A), (ii) the dis-
appearance of the sumoylated form upon overexpression
of the SUMO isopeptidase Ulp1 (Figure 1B), (iii) the
SUMO modiﬁcation of the endogenously expressed
SU(VAR)3-7 (Figure 1C), and iv) the identiﬁcation of
the lysine where the SUMO molecule is attached to
(Figure 1E and F). The SU(VAR)3-7 proteins expressed
from constructs transfected into S2 cells (GFP-Su(var)3-7,
3HA-Su(var)3-7) always give the same pattern in western
blot analysis, namely the SU(VAR)3-7 non-modiﬁed
form, and one additional band corresponding to the
sumoylated form (see, e.g. Figure 1A and F). A third
(and fourth, depending on the experiment) band of
higher molecular weight is detected in the HA:FL
(Supplementary Figure S2) and 3HA-Su(var)3-7 (Figure
1G) transgenics lines, or with the endogenous protein in
S2 cells (Figure 1C, Supplementary Figure S1A). We
propose that these bands correspond to SU(VAR)3-7
modiﬁed by two (or three) SUMO molecules. This hy-
pothesis is supported by immunoprecipitation experiments
(Figure 1C). The band corresponding to SU(VAR)3-7
carrying one SUMO molecule shows higher intensity
than the band with potentially two SUMO molecules
when detected with the a-SU(VAR)3-7. These two bands
show the same intensity when revealed by the a-SUMO,
potentially due to two SUMO molecules. We surmise that
those additional forms of SU(VAR)3-7 were not detected
in transfectants, because the SU(VAR)3-7 protein is ex-
pressed at higher level, and only one SUMO molecule
would be attached to a given SU(VAR)3-7 protein by its
speciﬁc SUMO E3-ligase. Nevertheless, the major
sumoylation site of SU(VAR)3-7 is the K839 position;
its mutation prevents or strongly reduces the presence of
all SUMO-modiﬁed SU(VAR)3-7 forms (Figures 1E–G),
and impairs the function of the protein. It would be inter-
esting—in a future study—to determine if those additional
SUMO molecules are bound in chain to the main SUMO
at position K839, or whether they are attached to other
lysines that would be secondary minor sites.
The SU(VAR)3-7 sumoylation target sequence
IK839VF is located in the middle of the seventh zinc
ﬁnger of the protein. This particular sequence is conserved
in Drosophila pseudobscura (Dpse), and highly similar
(IKLF) in Drosophila virilis (Dv) Su(var)3-7 orthologs
(9). The seventh zinc ﬁnger of SU(VAR)3-7 is the most
conserved part of the protein displaying 100% similarity
(9), reinforcing the functional importance of this domain
(see below) and of sumoylation at position K839.
Sumoylated lysines are usually embedded in the KxE/
D consensus. The consensus surrounding lysine K839 is
quite surprising, containing a phenylalanine (F) instead of
Heidi
+3HA-Su(var)3-7
(WT)
+3HA-Su(var)3-7
(K839R)
femalesmalesBA
females wm4h/yw
+
lwr5
+
lwr4-3
+
+ lwr5 lwr4-3 +
T21A T21A T21A
O
D 
48
0n
m
400
350
300
250
200
150
100
50
0
Figure 3. (A) Sumoylation is required for PEV. Repression of the variegating white gene in the In(1)wm4h line is relieved in the lwr heterozygous
mutant background (left part). Data are shown for the females; the same trend is observed in males, as well as in the Heidi line (data not shown).
The repression of the variegating white gene in the presence of an additional dose of Su(var)3-7 (T21A transgene) is also relived in the lwr
heterozygous mutant background (right part). Pictures were taken and quantiﬁcation of pigments was done 3 days after eclosion. The scale corres-
ponds to the absorption at OD 480 nm. Genotypes, from left to right: 1) In(1)wm4h / yw; + / lwr5 FRT40A. 2) In(1)wm4h / yw; + / lwr4-3
FRT40A. 3) In(1)wm4h / yw;+/+. 4) In(1)wm4h / yw; T21A / lwr5 FRT40A. 5) In(1)wm4h / yw; T21A / lwr4-3 FRT40A. 6) In(1)wm4h / yw;
T21A / +. (B) Sumoylation of SU(VAR)3-7 is required for PEV. The variegating white transgene in the Heidi line is further repressed upon
expression of 3HA-Su(var)3-7(WT), but not upon expression of 3HA-Su(var)3-7(K839R). Pictures were taken 2 days after eclosion. The eye
color phenotype was constant from ﬂy to ﬂy. Genotypes, from top: (i) yw; Heidi / +; P{daGal4.w} / +. (ii) yw; Heidi / P{UAST-3HA-
Su(var)3-7(WT); y+}; P{daGal4.w} / +. (iii) yw; Heidi / P{UAST-3HA-Su(var)3-7(K839R); y+}; P{daGal4.w} / +.
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a glutamic (E) or an aspartic (D) acid at the fourth
position. Such a variant was not found among several
sumoylation targets listed (28). Based solely on the con-
sensus sequence, the lysine K269 was a better candidate, as
it lies in the IK269HE environment, it is also conserved in
Dpse, and highly similar (VKHE) in Dv orthologs (9).
Nevertheless, functional data show that K839 and not
K269 is the main sumoylation target in SU(VAR)3-7
(Figures 1D and E). Recently, an early Drosophila embry-
onic ‘SUMO-ome’ (a catalog of sumoylated proteins) was
established, and SU(VAR)3-7 was identiﬁed, among 144
proteins, as a sumoylation substrate (33). Interestingly,
this study also revealed that ‘epigenetic regulation’ is
one of the six enriched functional groups of sumoylation
substrates.
Sumoylation of SU(VAR)3-7 is required for localiza-
tion at the chromocenter, telomeres, chromosome 4, and
region 31 (Figure 2A and B). It should be noted that in
conditions where the polytene chromosomes are ﬁxed
more strongly, some non-speciﬁc staining appears on the
chromosomes, for both the WT and the K839R forms,
most likely due to the fact that the proteins are present
in the nucleus, overexpressed, and contain several zinc
ﬁngers. The impairment in chromatin binding of the
SU(VAR)3-7(K839R) protein is not due to a defect in
nuclear import, as it is present in the nuclei of whole
mount salivary glands. This experiment also shows that
in intact tissue—in contrary to the wild-type form—the
3HA-SU(VAR)3-7(K839R) protein displays no preferen-
tial binding to the DAPI dense regions (Figure 2A). Since
SU(VAR)3-7 can homodimerize (39), localization experi-
ments were performed in a Su(var)3-7 mutant back-
ground. However, localization of SU(VAR)3-7(K839R)
was also assessed in Su(var)3-7 wild-type larvae. In this
context, the mutant form gives a signal at the chromo-
center, although not as strong as the SU(VAR)3-7(WT)
(Supplementary Figure S4). This argues in favor of a
conserved capacity of the SU(VAR)3-7(K839R) protein
to at least partially interact with the wild-type form.
Some truncated forms of SU(VAR)3-7 were shown to
have a dominant negative phenotype (39); the
SU(VAR)3-7(K839R) form does not behave in such a
way, as its overexpression does not suppress variegation
(Figure 3B). The absence of a dominant negative pheno-
type of the 3HA-SU(VAR)3-7(K839R) protein could
be due to a weaker association with the wild-type
SU(VAR)3-7. In addition, although it can associate with
the wild-type protein, the non-sumoylable SU(VAR)3-7
might not delocalize it from chromatin and therefore not
prevent its function.
The N-terminal part of SU(VAR)3-7 is composed of
seven widely spaced zinc ﬁngers (8) which have aﬃnity
for DNA in a non-heterochromatin-speciﬁc manner
(39,41). The C-terminal part contains BESS- and
BoxA-motifs, involved respectively in self-interaction
and in interaction with other heterochromatic partners
(9,39). Interestingly, while the C-terminal part of
SU(VAR)3-7 binds to heterochromatin only if endogen-
ous SU(VAR)3-7 is present, probably through homo-
dimerization, addition of the seventh zinc ﬁnger
containing the K839 sumoylation site or of the sixth zinc
ﬁnger together with the seventh zinc ﬁnger mutated for the
two cysteines but leaving the sumoylation site intact,
suﬃces for proper localization at pericentric heterochro-
matin, even in the absence of the wild-type protein (9).
Thus, together with the data presented here, we propose
that the ability for SU(VAR)3-7 to be sumoylated in its
seventh zinc ﬁnger is critical for its speciﬁc binding
to heterochromatin. The fact that sumoylation of
SU(VAR)3-7 is required for enhancement of PEV
(Figure 3A and B) is coherent with the observation that
the mutant protein does not co-localize with chromatin.
Moreover, in the lwr mutant background we observe a
suppression of variegation (Figure 3A), reinforcing our
view on the role of sumoylation for PEV. SU(VAR)3-7
is a substrate for sumoylation, but we cannot rule out that
other factors involved in PEV are modiﬁed by SUMO.
Taken together, these data decipher the importance of
sumoylation for heterochromatin function in Drosophila.
Interestingly, a similar mechanism was put forward in
Saccharomyces pombe, where Ubc9 sumoylates Swi6 and
Clr4 [the homologs of HP1 and SU(VAR)3-9]; SUMO
modiﬁcation of those two factors is required for the main-
tenance and silencing of heterochromatin (42). We
assessed whether Drosophila HP1 or SU(VAR)3-9 were
modiﬁed by SUMO, but could not detect even traces of
SUMO-modiﬁed forms (data not shown). An independent
recent study conﬁrmed that HP1 is not a sumoylation
substrate (33). Thus, sumoylation plays a role in hetero-
chromatin function, and this key modiﬁcation is carried
by HP1 and SU(VAR)3-9 homologs in Saccaromyces
pombe, and by SU(VAR)3-7 in Drosophila. As a model,
we propose that the SUMO modiﬁcation of SU(VAR)3-7
forms a new platform mediating interactions with for
instance repetitive heterochromatic DNA-sequences, or
with a heterochromatin-bound protein, for example HP1
or SU(VAR)3-9. In such a context, forming heterochro-
matin would recruit sumoylated SU(VAR)3-7 that would
in turn contribute to the condensed state.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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